abrotanum / artemisia abrotanum
boiron sa - artemisia eberraate - tm, d; tm, d - homöopathisch
abrotanum / artemisia abrotanum
boiron sa - artemisia eberraate - k30, d; lm/q1, d - homöopathisch
casirivimab et imdevimab solution
hoffmann-la roche limited - casirivimab; imdévimab - solution - 1332mg; 1332mg - casirivimab 1332mg; imdévimab 1332mg - monoclonal antibodies
casirivimab et imdevimab solution
hoffmann-la roche limited - casirivimab; imdévimab - solution - 300mg; 300mg - casirivimab 300mg; imdévimab 300mg - monoclonal antibodies
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - agents antinéoplasiques - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - des sérums et immunoglobulines, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. voir les sections 4. 4 et 5.
evusheld solution
astrazeneca canada inc - tixagévimab; cilgavimab - solution - 150mg; 150mg - tixagévimab 150mg; cilgavimab 150mg
benlysta poudre pour solution
glaxosmithkline inc - bélimumab - poudre pour solution - 120mg - bélimumab 120mg - immunosuppressive agents
benlysta poudre pour solution
glaxosmithkline inc - bélimumab - poudre pour solution - 400mg - bélimumab 400mg - immunosuppressive agents
benlysta solution
glaxosmithkline inc - bélimumab - solution - 200mg - bélimumab 200mg - immunosuppressive agents